1. Amos, H. E. and Brigden, W. D. (1976). Immunological changes and practolol. Lancet, ii, 1298
2. Amos, H. E., Brigden, W. D. and McKerron, R. A. (1975). Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue. Br. med. J, I, 598
3. Amos, H. E., Lake, B. G. and Atkinson, H. A. C. (1977). Allergic drug reactions; an in vitro model using a mixed function oxidase complex to demonstrate antibodies with specificity for a practolol metabolite.
4. Amos, H. E., Lake, B. G. and Artis, J. (1978). Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome. Br. med. J., I, 402
5. Assem, E. S. K. and Banks, R. A. (1973). Practolol induced drug eruption. Proc. R. Soc. Med., 66, 179